Completed
Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment
NCT02047253
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Birmingham VA Medical Center Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Cancer Life Center, Navicent Health Macon, Georgia, United States
- University of Tulane New Orleans, Louisiana, United States